Long-term treatment of essential hypertension with guanfacine: Effect on cardiovascular complications, renin and prolactin

References

• Bream J. B., Lauerner H., Picard C. W., Scholtysik G., Waite T. G. Substituted phenyl‐acetyl guanidine: a new class of antihypertensive agents. Arzneim. Forsch. 1975; 25: 14771. Bream J. B., Lauerner H., Picard C. W., Scholtysik G., Waite T. G. Substituted phenyl‐acetyl guanidine: a new class of antihypertensive agents. Arzneim. Forsch. 1975; 25: 1477
   PubMed Web of Science ®Google Scholar
• Friesen H., Belanger C., Guyda H., Hwang P. Lactogenic Hormones, G. E. W. Wolstenholme, J. Knights. Churchill‐Livingstone, London 1972; 832. Friesen H., Belanger C., Guyda H., Hwang P. Lactogenic Hormones, G. E. W. Wolstenholme, J. Knights. Churchill‐Livingstone, London 1972; 83
   Google Scholar
• Fyhrquist F., Kurppa K., Huuskonen M. Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine. Acta Med. Scand. 1975; 197: 4573. Fyhrquist F., Kurppa K., Huuskonen M. Plasma renin activity, blood pressure and sodium excretion during treatment with clonidine. Acta Med. Scand. 1975; 197: 457
   PubMed Web of Science ®Google Scholar
• Haber E., Kourner T., Page L., Klaurian B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurement of plasma renin activity in normal subjects. J. Clin. Endocrinol. Metab. 1969; 29: 13494. Haber E., Kourner T., Page L., Klaurian B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiological measurement of plasma renin activity in normal subjects. J. Clin. Endocrinol. Metab. 1969; 29: 1349
   PubMed Web of Science ®Google Scholar
• Hauger‐Klevene J. H. Active and inactive renin and prolactin in essential hypertension: effect of pindolol alone or in combination with elopamide and BS‐100/141. Proceedings of the International Symposium of Arterial Hypertension, M. Velasco. Excerpta Medica, Amsterdam 1979; 1295. Hauger‐Klevene J. H. Active and inactive renin and prolactin in essential hypertension: effect of pindolol alone or in combination with elopamide and BS‐100/141. Proceedings of the International Symposium of Arterial Hypertension, M. Velasco. Excerpta Medica, Amsterdam 1979; 129
   Google Scholar
• Hauger‐Klevene J. H. Renin levels and cardiovascular morbidity prospective study of the effect of beta adrenergic blocking drugs. Curr. Med. Res. Opin. 1981; 7: 4436. Hauger‐Klevene J. H. Renin levels and cardiovascular morbidity prospective study of the effect of beta adrenergic blocking drugs. Curr. Med. Res. Opin. 1981; 7: 443
   PubMed Web of Science ®Google Scholar
• Hauger‐Klevene J. H., Rastrilla A. M. Tratamiento prolongado de la hipertensión esencial grave con guanfacina: efecto en la reactividad vascular y sistema renina‐angiotensina‐aldosterona. Prensa Med. Arg. 1980; 67: 7407. Hauger‐Klevene J. H., Rastrilla A. M. Tratamiento prolongado de la hipertensión esencial grave con guanfacina: efecto en la reactividad vascular y sistema renina‐angiotensina‐aldosterona. Prensa Med. Arg. 1980; 67: 740
   Google Scholar
• Hauger‐Klevene J. H., Pinkas M. B., Gerber S. Blood pressure and prolactin: effect of BS‐100/141. Hypertension. 1981, Accepted for publication8. Hauger‐Klevene J. H., Pinkas M. B., Gerber S. Blood pressure and prolactin: effect of BS‐100/141. Hypertension. 1981, Accepted for publication
   PubMedGoogle Scholar
• Hauger‐Klevene J. H., Sccornavacchi J. C., Rastrilla A. M., Pinkas M. B., Grossman M. Mechanism of action of central antihypertensive drugs: BS‐100/131 and bromo‐ergocriptine in essential hypertension and active acromegaly: effect on plasma renin activity, prolactin and pressure response to angiotensin II. Proceedings of the International Symposium of Arterial Hypertension, M. Velasco. Excerpta Medica, Amsterdam 1979; 2629. Hauger‐Klevene J. H., Sccornavacchi J. C., Rastrilla A. M., Pinkas M. B., Grossman M. Mechanism of action of central antihypertensive drugs: BS‐100/131 and bromo‐ergocriptine in essential hypertension and active acromegaly: effect on plasma renin activity, prolactin and pressure response to angiotensin II. Proceedings of the International Symposium of Arterial Hypertension, M. Velasco. Excerpta Medica, Amsterdam 1979; 262
   Google Scholar
• Jerie P. Clinical experience with guanfacine in long‐term treatment of hypertension. Part I. Br. J. Clin. Pharmacol. 1980; 10: 37S10. Jerie P. Clinical experience with guanfacine in long‐term treatment of hypertension. Part I. Br. J. Clin. Pharmacol. 1980; 10: 37S
   PubMed Web of Science ®Google Scholar
• Jerie P. Clinical experience with guanfacine in long‐term treatment of hypertension: Part II: Adverse reactions to guanfacine. Br. J. Clin. Pharmacol. 1980; 10: 157S11. Jerie P. Clinical experience with guanfacine in long‐term treatment of hypertension: Part II: Adverse reactions to guanfacine. Br. J. Clin. Pharmacol. 1980; 10: 157S
   PubMed Web of Science ®Google Scholar
• Kalberg B., Nilsson O., Tolangen K. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone. Curr. Ther. Res. 1977; 21: 1012. Kalberg B., Nilsson O., Tolangen K. Clonidine in primary hypertension: effects on blood pressure, plasma renin activity, plasma and urinary aldosterone. Curr. Ther. Res. 1977; 21: 10
   PubMed Web of Science ®Google Scholar
• Manhem P., Hökfelt B. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension. Br. J. Clin. Pharmacol. 1980; 10: 10913. Manhem P., Hökfelt B. Blood pressure, heart rate, catecholamines and plasma renin activity following institution and withdrawal of guanfacine treatment in moderate hypertension. Br. J. Clin. Pharmacol. 1980; 10: 109
   PubMedGoogle Scholar
• Putzeys M. R., Hoobler S. W., Arbor A. Comparison of clonidine and methyldopa on blood pressure and side‐effects in hypertensive patients. Am. Heart J. 1972; 83: 46414. Putzeys M. R., Hoobler S. W., Arbor A. Comparison of clonidine and methyldopa on blood pressure and side‐effects in hypertensive patients. Am. Heart J. 1972; 83: 464
   PubMed Web of Science ®Google Scholar
• Rosenthal J. Effect of guanfacine on blood pressure and renin activity in hypertensive patients. Br. J. Clin. Pharmacol. 1980; 10: 91S15. Rosenthal J. Effect of guanfacine on blood pressure and renin activity in hypertensive patients. Br. J. Clin. Pharmacol. 1980; 10: 91S
   PubMed Web of Science ®Google Scholar
• Saameli K., Scholtysik G., Watte R. Pharmacology of BS‐100/141, a centrally acting antihypertensive drug. Clin. Exp. Pharmacol. Physiol. 1975; 2: 20716. Saameli K., Scholtysik G., Watte R. Pharmacology of BS‐100/141, a centrally acting antihypertensive drug. Clin. Exp. Pharmacol. Physiol. 1975; 2: 207
   PubMed Web of Science ®Google Scholar
• Schoepe W., Brecht H. M. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity. Br. J. Clin. Pharmacol. 1980; 10: 97517. Schoepe W., Brecht H. M. Guanfacine in essential hypertension: effect on blood pressure, plasma noradrenaline concentration and plasma renin activity. Br. J. Clin. Pharmacol. 1980; 10: 975
   Google Scholar
• Zanchetti A., Stella A., Dampney R. Central and reflex control of renin release. Prog. Brain Res. 1977; 47: 39718. Zanchetti A., Stella A., Dampney R. Central and reflex control of renin release. Prog. Brain Res. 1977; 47: 397
   PubMedGoogle Scholar